Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.39)
# 2,617
Out of 5,090 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $52 → $49 | $47.01 | +5.17% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $145.49 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $157.21 | +389.79% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $48.03 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $73.62 | -7.63% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $11.25 | +486.67% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $128.96 | +123.33% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $572.77 | -54.61% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $394.81 | -46.56% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $7.09 | +661.64% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $244.55 | -83.23% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $317.69 | +5.45% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $317.05 | +5.66% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $52 → $49
Current: $47.01
Upside: +5.17%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $145.49
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $157.21
Upside: +389.79%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $48.03
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $73.62
Upside: -7.63%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $11.25
Upside: +486.67%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $128.96
Upside: +123.33%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $572.77
Upside: -54.61%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $394.81
Upside: -46.56%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $7.09
Upside: +661.64%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $244.55
Upside: -83.23%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $317.69
Upside: +5.45%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $317.05
Upside: +5.66%